Clinical Trials Browser

Terminated × Head and Neck Neoplasms × Standard of Care × Clear all

NCT00412217 2016-11-25

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Phase 3 Terminated

94 enrolled 6 charts

Head and Neck Neoplasms

NCT00574860 2013-09-20

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

Phase 3 Terminated

Head and Neck Neoplasms, Stomatitis